We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AGY market cap is 215.68M. The company's latest EPS is GBP -0.0090 and P/E is -5.02.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 73.72M | 78.2M | 84.33M | 72.77M | 59.59M |
Operating Income | 4.98M | 10.06M | 2.03M | -14.21M | -38.77M |
Net Income | 3.47M | 7.06M | 2.89M | -13.78M | -43.07M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 68.5M | 86.23M | 88.09M | 72.95M | 66.77M |
Total Liabilities | 30.94M | 42.44M | 39.55M | 35.18M | 64.7M |
Total Equity | 37.56M | 43.78M | 48.54M | 37.77M | 2.07M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | 5.6M | 12.01M | 8.4M | -14M | -28.88M |
Investing | -3.35M | -2.51M | -2.64M | -3M | -4.59M |
Financing | 9.55M | -110k | -2.03M | -2.81M | 27.8M |
Market Cap | 215.68M |
Price to Earnings Ratio | -5.02 |
Price to Sales Ratio | 3.62 |
Price to Cash Ratio | 14.58 |
Price to Book Ratio | 104.28 |
Dividend Yield | - |
Shares Outstanding | 4.77B |
Average Volume (1 week) | 400.51k |
Average Volume (1 Month) | 384.46k |
52 Week Change | 81.00% |
52 Week High | 6.05 |
52 Week Low | 1.275 |
Spread (Intraday) | 0.45 (9.47%) |
Company Name | Allergy Therapeutics Plc |
Address |
dominion way west sussex BN14 8SA |
Website | https://www.allergytherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions